16 March 2022 - Deborah Wilkes
Premium
GlaxoSmithKline (GSK) has appointed six directors to the Board of Haleon, the standalone company that will be formed through the planned demerger of GSK Consumer Healthcare in July 2022.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.